[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100553536":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":29,"locations":35,"responsibleParty":57,"collaborators":10,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":10,"eligibilityCriteria":67,"healthyVolunteers":63,"sex":68,"minAge":69,"maxAge":70,"enrollmentInfo":71,"targetDuration":74,"studyType":75,"phases":10,"briefSummary":76,"conditions":77,"keywords":79,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"Karadeniz Technical University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Physiotherapy Group",null,"There will be only one group in the study. Patients will only be applied to the physiotherapy program recommended by the specialist physician and physiotherapist. It is not possible to apply any additional treatment within the scope of the study.",[13],"Other: Rehabilitation",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Rehabilitation","A routine physical therapy program prescribed by a specialist physician and physiotherapist will be applied.",[9],[20,23,26],{"name":21,"affiliation":5,"role":22},"Murat Emirzeoğlu, PhD","STUDY_CHAIR",{"name":24,"affiliation":25,"role":22},"Adem Aktürk, PhD","İstanbul Gelişim University",{"name":27,"affiliation":28,"role":22},"Tuğba Eyigürbüz, PhD","Bağcılar Education and Research Hospital",[30],{"name":31,"role":32,"phone":33,"phoneExt":10,"email":34},"Emre Şenocak, PhD","CONTACT","+90 553 569 56 92","emre.senocak@windowslive.com",[36],{"facility":37,"status":38,"city":39,"state":10,"zip":40,"country":41,"countryCode":10,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Private Güney Hospital","RECRUITING","Istanbul","34230","Turkey (Türkiye)",{"type":43,"coordinates":44},"Point",[45,46],28.94966,41.01384,{"lat":46,"lon":45},[49,53],{"name":50,"role":32,"phone":51,"phoneExt":10,"email":52},"Call Center, Personel of Call Center","+90 212 645 16 16","bilgiislem@guneyhastanesi.com",{"name":54,"role":32,"phone":55,"phoneExt":10,"email":56},"Adem Aktürk, PhD (Also: Medical Doctor)","+90 533 310 23 15","aakturk@gelisim.edu.tr",{"type":58,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Emre Şenocak","Research Assisstant","100553536","determination-of-the-minimal-detectable-change-of-the-parkinsons-disease-questionnaire-8-100553536",false,"NCT06487364","Determination of the Minimal Detectable Change of the Parkinson's Disease Questionnaire-8","Determination of the Minimal Detectable Change and Minimum Clinically Important Change Score of the Parkinson's Disease Questionnaire-8","Inclusion Criteria:\n\n* Having regular neurology follow-up and using medicine;\n* Hoehn and Yahr Scale Stage between 1-3 points;\n* Mini-Mental State Assessment Score \\>24 points;\n\nExclusion Criteria:\n\n* Having a secondary neurological disease;\n* Any surgery and\u002For trauma affecting the upper extremity\n* Having complaints of pain before the treatment program;\n* There was a change in medical treatment during the study;\n* With symptoms of anxiety and depression;\n* Those who use alcohol and drugs;\n* Individuals with vision defects that cannot be corrected by the use of glasses and those with hearing loss","ALL","40 Years","80 Years",{"count":72,"type":73},39,"ESTIMATED","30 Days","OBSERVATIONAL","This study is conducted to determine how many units of improvement the Parkinson's Disease Questionnaire-8 (PDQ-8), used to evaluate the quality of life of Parkinson's patients, should have to express a significant change in the quality of life. Patients for whom a 30-session physiotherapy program is recommended will be included in the study. Patients will be asked to express the change in their quality of life at the end of treatment. The PDQ-8 survey and Global Rating of Patient-Perceived Changes (GRP-PC) forms will be used to determine these changes. Evaluations will be repeated at the beginning of the treatment program and at the end of the 30th session.",[78],"Parkinson Disease",[80,81,82,83],"Parkinson","Minimal Detectable Change","Minimal Clinically Important Difference","Parkinson Disease Questionnaire-8","2025-03-04",{"date":86,"type":87},"2025-03-05","ACTUAL",{"date":89,"type":87},"2024-05-13",{"date":91,"type":73},"2025-09-17",{"name":59,"class":6},1]